US Patent 7407932 Methods for glucagon suppression using modified exendins
Patent 7407932 was granted and assigned to Amylin Pharmaceuticals on August, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+464 characters)
Article
Patent abstract
Methods for use of an exendin, an exendin agonist, or a modified exendin or exendin agonist having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, for lowering glucagon levels and/or suppressing glucagon secretion in a subject are provided. These methods are useful in treating hyperglucagonemia and other conditions that would be benefited by lowering plasma glucgon or suppressing glucagon secretion.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07407932 Methods for glucagon suppression using modified exendins US Patent 7407932 Methods for glucagon suppression using modified exendins
Infobox
Patent Number
0740793200
Patent Number
740793200
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074079320
Date of Patent
August 5, 2008
0Patent Application Number
115841140
Date Filed
October 19, 2006
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074079320
Date of Patent
August 5, 2008
0Patent Application Number
115841140
Date Filed
October 19, 2006
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07407932 Methods for glucagon suppression using modified exendins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07407932
Date of patent
August 5, 2008
Patent application number
11584114
Date Filed
October 19, 2006
Patent primary examiner
Find more entities like US Patent 7407932 Methods for glucagon suppression using modified exendins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
